Tofacitinib - PDFSEARCH.IO - Document Search Engine

Tofacitinib
Results: 22

#	Item
1	------------------------DOSAGE AND ADMINISTRATION---------------------Rheumatoid Arthritis  Recommended dose of XELJANZ is 5 mg twice daily. (2.1)  Moderate and severe renal impairment and moderate hepatic impairme Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2015-06-22 13:44:18 Medicine Clinical medicine Immunosuppressants Tuberculosis Tofacitinib Azathioprine Tuberculosis management Latent tuberculosis Anakinra Alefacept
2	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STIVARGA safely and effectively. See full prescribing information for STIVARGA.  Dermatological toxicity: Interr Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2015-04-14 15:23:06 RTT Nonsteroidal anti-inflammatory drugs Pyridines Regorafenib Ureas Adverse effect Ibuprofen Anakinra Tofacitinib
3	HIGHLIGHTS OF PRESCRIBING INFORMATION These hig hlights do not include all the informatio n nee ded to use VOTRIENT safely and effectively. See full prescribing information for VOTRIENT. gastrointestinal perforation or Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2015-04-02 10:46:40 Medicine Organofluorides Clinical medicine Chemistry Nonsteroidal anti-inflammatory drugs Indoles Pyrroles Sunitinib Statin Ibuprofen Adverse effect Tofacitinib
4	Tofacitinib for chronic plaque psoriasis – second line Add to Reading List Source URL: www.hsc.nihr.ac.uk Language: English
5	542 CONCISE REPORT Formative research in clinical trial development: attitudes of patients with arthritis in enhancing prevention trials Add to Reading List Source URL: www.ncbi.nlm.nih.gov Language: English Arthritis Rheumatoid arthritis Rheumatologists Rheumatology Disease-modifying antirheumatic drug Placebo Tofacitinib Anakinra Medicine Health Immunosuppressants
6	s p e c i a l f e at u r e © John Bavosi / Photo Researchers, Inc. Osteoarthritis and Rheumatoid Arthritis 2012: Add to Reading List Source URL: www.nphealthcarefoundation.org Language: English - Date: 2012-10-29 11:36:28 Anatomy Rheumatology Immunosuppressants Connective tissue diseases Autoimmune diseases Rheumatoid arthritis Osteoarthritis Disease-modifying antirheumatic drug Tofacitinib Health Medicine Arthritis
7	THE PIPELINE REPORT[removed]PHARMA’S FRONTRUNNERS Profiling a dozen agents on deck Add to Reading List Source URL: media.mmm-online.com Language: English - Date: 2013-05-21 21:35:48 Pyridines Benzamides Bristol-Myers Squibb Organofluorides Dipeptidyl peptidase-4 inhibitor Tofacitinib Pfizer GlaxoSmithKline Axitinib Chemistry Organic chemistry Carbamates
8	Downloaded from http://ard.bmj.com/ on November 25, [removed]Published by group.bmj.com 290 REVIEW Early referral recommendation for newly diagnosed Add to Reading List Source URL: ard.bmj.com Language: English Anatomy Rheumatology Rheumatoid arthritis Disease-modifying antirheumatic drug Osteoarthritis Tofacitinib Peter K. Gregersen Health Medicine Arthritis
9	REMS Initial REMS Approval: [removed]Most Recent Modification: [removed]NDA 203,214 XELJANZ® (TOFACITINIB) Add to Reading List Source URL: www.fda.gov Language: English Immunology Rheumatoid arthritis Methotrexate Tofacitinib Azathioprine Disease-modifying antirheumatic drug Rheumatology Pfizer Leflunomide Immunosuppressants Medicine Pharmacology
10	Microsoft Word - pdl_notice_tesamorelin_tofacitinib_ldo_avis-fra.docx Add to Reading List Source URL: hc-sc.gc.ca Language: French - Date: 2014-05-12 14:23:37

UPDATE